Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Lipids in Health and Disease|June 26, 2024
Sex differences in lipidomic and bile acid plasma profiles in patients with and without coronary artery diseaseBenjamin Bay, Marceline M Fuh, Julia Rohde, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 20, 2024
Inflammatory risk and clinical outcomes according to polyvascular atherosclerotic disease status in patients undergoing PCIBenjamin Bay, Birgit Vogel, Raman Sharma, et al.American Heart Journal|June 21, 2026
Prognostic Impact of Combined Inflammatory Markers in Patients Undergoing Percutaneous Coronary InterventionFrancesca Maria Di Muro, Valeria Raona, Samantha Sartori, et al.The American Journal of Cardiology|May 2, 2024
Impact of Polyvascular Disease in Patients Undergoing Unprotected Left Main Percutaneous Coronary InterventionBenjamin Bay, Raman Sharma, Anastasios Roumeliotis, et al.Atherosclerosis|October 10, 2025
Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary interventionAngelo Oliva, Mark Shneyderman, Mauro Gitto, et al.Scientific Reports|December 8, 2023
Inflammatory burden, lifestyle and atherosclerotic cardiovascular disease: insights from a population based cohort studyBenjamin Bay, Christopher Blaum, Caroline Kellner, et al.European Journal of Preventive Cardiology|December 21, 2024
Validation of a High Bleeding Risk Definition in Cancer Patients undergoing Percutaneous Coronary InterventionMauro Gitto, Sean Gilhooley, Kenneth Smith, et al.The American Journal of Cardiology|March 29, 2026
Clinical Differences and Disparities Among Men and Women with Acute Myocardial Infarction-Related Cardiogenic Shock Undergoing Percutaneous Coronary InterventionMadison Edens, Angelo Oliva, Samantha Sartori, et al.The American Journal of Cardiology|October 24, 2024
Clinical Outcomes After Percutaneous Coronary Intervention for Left Main Coronary Artery Disease in Patients of Diverse Race/EthnicityPier Pasquale Leone, Samantha Sartori, Jonathan Murphy, et al.The Canadian Journal of Cardiology|March 9, 2025
Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary InterventionMauro Gitto, Samantha Sartori, Birgit Vogel, et al.Pageof 5